TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. gibt bekannt, dass die Europäische Kommission (EK) eine Marktzulassung für Ranivisio (Ranibizumab) erteilt hat, ein Biosimilar des Augenheilmittels Lucentis für alle fünf Indikation…
Author: Business Wire
Riassunto: La Commissione europea concede l'autorizzazione all'immissione in commercio per Ranivisio▼®* (ranibizumab), un biosimilare di Lucentis®**, per la degenerazione maculare senile (DMS), la causa più comune di cecità nei paesi sviluppati
TEL AVIV, Israele–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. annuncia che la Commissione europea (CE) ha rilasciato l’autorizzazione all’immissione in commercio per Ranivisio (ranibizumab), un biosimilare del trattamento oftalmico Lucentis, …
Optometry Equipment Market Report 2022: Increasing Incidence of Eye Disorders and Rising Technological Advancements in Ophthalmic Devices Drive Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamps, Wavefront Analyzer), Application(General Examination, Cataract, Glaucoma, Macular Degeneration), End User(Clinics, Hospitals) – …
Samenvatting: Europese Commissie verleent handelsvergunning voor Ranivisio▼®* (ranibizumab), een biosimilar van Lucentis®**, voor age-related macular degeneration(AMD) de meest voorkomende oorzaak van blindheid in ontwikkelde landen
TEL AVIV, Israël–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. kondigt aan dat de Europese Commissie (EC) een vergunning voor het in de handel brengen heeft verleend voor Ranivisio (ranibizumab), een biosimilar van de oogheelkundige behandeling…
近视改善效果得到证明的自然光照明SunLike照亮YBM苹果树
韓国安山–(BUSINESS WIRE)–掀起婴幼儿教育热潮的韓国江南地区“YBM开浦苹果树”语言培训班决定采用首尔半导体的自然光照明SunLike。
SunLike Lighting, With Proven Effectiveness of Myopia Improvement, to Light up a Major English-Speaking Kindergarten in Korea
ANSAN, South Korea–(BUSINESS WIRE)– #KOSDAQ046890–Seoul Semiconductor supplies SunLike lighting to YBM Appletree, Korea’s top-level English-speaking kindergartens, to help correct students’ myopia.
近視改善の効果が立証された自然光照明「サンライク」、YBM アップルツリーの照明に
韓国安山市–(BUSINESS WIRE)–幼児教育ブームが巻き起こっている韓国江南地域のYBM 開浦アップルツリー語学学院はソウル半導体の自然光「サンライク」照明を採用した。
European Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucentis®**, for age-related macular degeneration (AMD) the most common cause of blindness in developed countries
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. announces that the European Commission (EC) has granted a Marketing Authorization for Ranivisio (ranibizumab), a biosimilar of the ophthalmology treatment Lucentis across all five i…
The Worldwide Glaucoma Treatment Industry is Expected to Reach $9.1 Billion by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Glaucoma Treatment Market (2022-2027) by Type, Indication, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. …
North America Ophthalmic Drug Delivery System Market to Reach $12.8 Billion by 2031 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North America Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Nort…
ValenzaBio Appoints Industry Veteran Peter Greenleaf to its Board of Directors
BETHESDA, Md.–(BUSINESS WIRE)–ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, today announced the appointment of Peter Greenleaf to its board of directors. M…
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Glaukos Licenses Iveena’s Investigational Keratoconus Therapy
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems Inc. (“iVeena”), a clinical stage biopharmaceutical company with developmental products in keratoconus and pediatric myopia, has entered into a strategic licensing agreement with Glaukos Corporat…
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
GENEVA & DURHAM, N.C.–(BUSINESS WIRE)–Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), a pharmaceutical company focused on the …
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
GENEVA & DURHAM, N.C.–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), a pharmaceutical company focused on the discovery, develo…
Zenni Doubles Down on Innovation and Brand to Fuel Growth with New C-Suite Additions
NOVATO, Calif.–(BUSINESS WIRE)– #Eyewear–Zenni, the online eyewear retail leader, announced today two new key hires to its C-suite to support its continued growth.
Aurion Biotech Nominated for Prix Galien Startup Award
SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has been nominated for the prestigious Prix Galien Startup Award. Th…
Verséa Holdings, Inc. welcomes Rob Sambursky, MD, as President to lead the company’s expansion into the ophthalmic market
TAMPA, Fla.–(BUSINESS WIRE)– #industrynews–Verséa Holdings, Inc., welcomes Rob Sambursky, MD, as President to lead the company’s expansion into the ophthalmic market.
Retina Consultants of America Adds Austin Practice to Nationwide Network
AUSTIN, Texas–(BUSINESS WIRE)–Retina Consultants of America continues its growth in Texas, announcing alliance with Austin Retina Associates
Mann Eye Institute Selects ModMed’s All-in-One Software Solution for All Practices and New State-of-the-Art Ophthalmology Institute
BOCA RATON, Fla.–(BUSINESS WIRE)–When Mann Eye Institute of Texas sought to expand its operations and create a national hub for ophthalmology innovation, it chose all-in-one software solutions from practice technology leader ModMed®, designed to boos…